Oct 11, 2013
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.
Oct 10, 2013
Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, can significantly reduce damage to the heart during a myocardial infarction.
Oct 09, 2013
A group of Brigham and Women's Hospital, and Harvard Stem Cell Institute researchers, and collaborators at MIT and Massachusetts General Hospital have found a way to use stem cells as drug delivery vehicles.
Oct 08, 2013
A global hunt for genes that influence heart disease risk has uncovered 157 changes in human DNA that alter the levels of cholesterol and other blood fats - a discovery that could lead to new medications.
Oct 04, 2013
The International Atherosclerosis Society (IAS) and Pfizer Independent Grants for Learning & Change (IGLC) have announced their collaboration on a new grant opportunity focused on improving care for patients around the world with cardiovascular risk.
Oct 03, 2013
Researchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment with wound dressings made from human skin grown in vitro
Oct 02, 2013
A bioinformatics approach to repurposing drugs resulted in identification of a class of antidepressants as a potential new treatment for small-cell lung cancer (SCLC).
Oct 01, 2013
Olivier Brandicourt (57) has been appointed Chairman of the Board of Management of Bayer HealthCare and member of the Bayer AG Executive Council effective November 1, 2013.
Sep 27, 2013
Bayer HealthCare today announced that the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products Development has granted two separate orphan drug designations for its investigational, oral medication riociguat
Sep 26, 2013
Viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.